Heartland Institute for Clinical and Translational Research

堪萨斯大学哈特兰临床与翻译研究所(HICTR)是 成立于2007年，以响应国家CTSA倡议。卢旺达问题国际法庭的愿景是改善 堪萨斯州的健康，通过创建一家新颖的、变革性的翻译研究企业，从BENCH到 从床边到社区。我们的HICTR方案的特殊优势是创业药物和设备 发现和开发计划，以及一个发展良好、高度成功的基于社区的 研究计划。H卢旺达问题国际法庭的具体目标是：1)创建一个具有创新精神的新学术家园 临床和翻译研究人员的培训计划；2J提供增强的协调 翻译研究基础设施；以及3)积极让社区参与开发、测试和 通过利用和扩大现有网络传播研究，以改善所有人的健康 堪萨斯州？尤其是那些农村、服务不足和其他目标社区的人。拟议的基础设施 卢旺达问题国际法庭的教育计划将解决临床和翻译面临的挑战 调查人员通过增强和整合现有资源以更轻松地访问，开发新的创新 资源，并利用驻留在整个大学的研究中心的资源，包括我们的KINBRE 和五个科布雷奖助金，以及我们的卢旺达问题国际法庭网络机构。为了支持我们的目标，我们有 整合了大量的机构、企业和社区资源， 以及建立卢旺达问题国际法庭。卢旺达问题国际法庭将提供新的基础设施、培训和教育。 支持研究人员临床和转化研究的计划-将实验室发现放在第一位 人体试验(T1研究)和将研究转移到传播和实施研究 将研究成果付诸实践(T2研究)。在非凡的机构和社区支持下，我们 已经取得了巨大的进步。来自CTSA项目的资金将使加州大学 堪萨斯州的HICTR有机会充分实现其潜力，不仅对我们地区，而且对 国家CTSA联盟。

The University of Kansas Heartland Institute for Clinical and Translational Research (HICTR) was established in 2007 in response to the national CTSA Initiative. The vision of the HICTR is to Improve the health of Kansans by creating a novel and transformative translational research enterprise from bench to bedside to community. Particular strengths of our HICTR program are an entrepreneurial drug and device discovery and development program and a well-developed and highly accomplished community-based research program. The specific aims of the HICTR are to: 1) create a new academic home with innovative training programs for clinical and translational investigators; 2j provide an enhanced coordinated translational research infrastructure; and 3) actively engage the community in developing, testing, and disseminating research, by capitalizing on and expanding existing networks, to improve the health of all Kansans¿especially those in rural, underserved and other target communities. The proposed Infrastructure and educational programs of the HICTR will address the challenges facing clinical and translational investigators by enhancing and integrating existing resources for easier access, developing new innovative resources, and capitalizing on resources residing in research centers across the university¿including our KINBRE and five COBRE grants~and our HICTR network institutions. In support of our aims, we have marshaled an impressive array of institutional, corporate, and community resources in planning, developing, and establishing the HICTR. The HICTR will provide new infrastructure and training and educational programs to support investigators' clinical and translational research¿taking laboratory discoveries to first trials in humans (T1 research) and moving research through to studies on dissemination and implementation of research findings to practice (T2 research). With extraordinary institutional and community support, we already have made tremendous progress. Funding from the CTSA program will allow the University of Kansas' HICTR the opportunity to fully realize its potential not only for our region, but also to contribufe to the national CTSA Consortium.